Cargando…

mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway

Antisense technology can reduce gene expression via the RNase H1 or RISC pathways and can increase gene expression through modulation of splicing or translation. Here, we demonstrate that antisense oligonucleotides (ASOs) can reduce mRNA levels by acting through the no-go decay pathway. Phosphorothi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Xue-hai, Nichols, Joshua G, Hsu, Chih-Wei, Vickers, Timothy A, Crooke, Stanley T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649848/
https://www.ncbi.nlm.nih.gov/pubmed/31165876
http://dx.doi.org/10.1093/nar/gkz500
_version_ 1783438061534707712
author Liang, Xue-hai
Nichols, Joshua G
Hsu, Chih-Wei
Vickers, Timothy A
Crooke, Stanley T
author_facet Liang, Xue-hai
Nichols, Joshua G
Hsu, Chih-Wei
Vickers, Timothy A
Crooke, Stanley T
author_sort Liang, Xue-hai
collection PubMed
description Antisense technology can reduce gene expression via the RNase H1 or RISC pathways and can increase gene expression through modulation of splicing or translation. Here, we demonstrate that antisense oligonucleotides (ASOs) can reduce mRNA levels by acting through the no-go decay pathway. Phosphorothioate ASOs fully modified with 2′-O-methoxyethyl decreased mRNA levels when targeted to coding regions of mRNAs in a translation-dependent, RNase H1-independent manner. The ASOs that activated this decay pathway hybridized near the 3′ end of the coding regions. Although some ASOs induced nonsense-mediated decay, others reduced mRNA levels through the no-go decay pathway, since depletion of PELO/HBS1L, proteins required for no-go decay pathway activity, decreased the activities of these ASOs. ASO length and chemical modification influenced the efficacy of these reagents. This non-gapmer ASO-induced mRNA reduction was observed for different transcripts and in different cell lines. Thus, our study identifies a new mechanism by which mRNAs can be degraded using ASOs, adding a new antisense approach to modulation of gene expression. It also helps explain why some fully modified ASOs cause RNA target to be reduced despite being unable to serve as substrates for RNase H1.
format Online
Article
Text
id pubmed-6649848
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-66498482019-07-29 mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway Liang, Xue-hai Nichols, Joshua G Hsu, Chih-Wei Vickers, Timothy A Crooke, Stanley T Nucleic Acids Res Molecular Biology Antisense technology can reduce gene expression via the RNase H1 or RISC pathways and can increase gene expression through modulation of splicing or translation. Here, we demonstrate that antisense oligonucleotides (ASOs) can reduce mRNA levels by acting through the no-go decay pathway. Phosphorothioate ASOs fully modified with 2′-O-methoxyethyl decreased mRNA levels when targeted to coding regions of mRNAs in a translation-dependent, RNase H1-independent manner. The ASOs that activated this decay pathway hybridized near the 3′ end of the coding regions. Although some ASOs induced nonsense-mediated decay, others reduced mRNA levels through the no-go decay pathway, since depletion of PELO/HBS1L, proteins required for no-go decay pathway activity, decreased the activities of these ASOs. ASO length and chemical modification influenced the efficacy of these reagents. This non-gapmer ASO-induced mRNA reduction was observed for different transcripts and in different cell lines. Thus, our study identifies a new mechanism by which mRNAs can be degraded using ASOs, adding a new antisense approach to modulation of gene expression. It also helps explain why some fully modified ASOs cause RNA target to be reduced despite being unable to serve as substrates for RNase H1. Oxford University Press 2019-07-26 2019-06-05 /pmc/articles/PMC6649848/ /pubmed/31165876 http://dx.doi.org/10.1093/nar/gkz500 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Molecular Biology
Liang, Xue-hai
Nichols, Joshua G
Hsu, Chih-Wei
Vickers, Timothy A
Crooke, Stanley T
mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway
title mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway
title_full mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway
title_fullStr mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway
title_full_unstemmed mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway
title_short mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway
title_sort mrna levels can be reduced by antisense oligonucleotides via no-go decay pathway
topic Molecular Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649848/
https://www.ncbi.nlm.nih.gov/pubmed/31165876
http://dx.doi.org/10.1093/nar/gkz500
work_keys_str_mv AT liangxuehai mrnalevelscanbereducedbyantisenseoligonucleotidesvianogodecaypathway
AT nicholsjoshuag mrnalevelscanbereducedbyantisenseoligonucleotidesvianogodecaypathway
AT hsuchihwei mrnalevelscanbereducedbyantisenseoligonucleotidesvianogodecaypathway
AT vickerstimothya mrnalevelscanbereducedbyantisenseoligonucleotidesvianogodecaypathway
AT crookestanleyt mrnalevelscanbereducedbyantisenseoligonucleotidesvianogodecaypathway